Guidance for market authorization requirements for COVID-19 vaccines: Quality, manufacturing and lot release requirements (English, HTML)

Guidance for market authorization requirements for COVID-19 vaccines: Quality, manufacturing and lot release requirements: English HTML file. From Health Canada, updated Jul 2021. View metadata, licence and the direct download on CanQuery.

Format
HTML
Access
Original download only
Publisher-reported update
2021-07-29

COVID-19 vaccines must be manufactured under good manufacturing practices (GMP) conditions. These conditions must be in line with international requirements, which are outlined in the International Council for Harmonization Q7A guideline and applicable Health Canada guidance.

Access original file

Data overview

Formats
HTML
File languages
English
Available actions
Access original file

Official sources and licences

Related open data